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Objectives: To evaluate the effects of introducing routine ultrasonic screening for the identification a d elective surgical 
treatment of abdominal ortic aneurysms (AAA) at high risk of rupture in the U.K. population of men aged 65-74 
years. 
Design: A computer assisted simulation of an AAA screening programme. The simulation incorporated assumptions 
gleaned from the literature about he epidemiology of AAA and the costs of screening. Inaddition, up to date costings based 
on recent Manchester (U.K.) vascular surgery experience are used. 
Setting: A dialogue between National Health Service commissioners and providers to explore the feasibility and desirability 
of introducing AAA screening. 
Chief outcome measure: Cost per quality adjusted life year (QALY) gained. 
Main results: The absolute cost (circa 1992/3) per QALY gained from screening for and treating aneurysms of ~ 6cm in 
diameter is£1500 (benefit not discounted). Offsetting current reatment costs of ruptured aneurysms gives a net additional 
cost per QALY of£1300. Screening and treating aneurysms of ~ 5cm leads to a cost per QALY gained exceeding £20000. 
The findings are robust under sensitivity analysis. 
Conclusions: Routine screening for AAAs of size ~ 6cm compares favourably in terms of cost per QALY gained with 
services such as breast and cervical cancer screening. 
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Introduction 
There has been a progressive increase of recorded 
deaths from abdominal aortic aneurysms (AAA) in the 
U.K. over the last 30 years) Ruptured aneurysms kill 
more than 4000 men over the age of 60 years in 
England and Wales each year and account for 1.9% of 
male deaths in t~s age range. More than half of these 
deaths occur between the ages 70-79 years. Ruptured 
AAA is less common in women accounting for only 
0.7% of deaths over the age of 60 years. 2
In the past decade surgical and anaesthetic tech- 
niques have improved rapidly such that mortality 
rates associated with elective aneurysm surgery are 
now less than 5%. 3 Successfully repaired aneurysms 
appear to effect complete cure. 4 In stark contrast there 
is a high mortality associated with ruptured aneu- 
rysms: up to 64% of patients die before they reach 
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hospital and many others die in the hospital before 
they reach the operating theatre) '5-9 Even if the 
patient does reach the operating theatre alive the 
mortality rate across the U.K. averages 70%. The 
overall mortality rate from rupture is of the order of 
80-94% .10 
The key to better survival is the detection of 
asymptomatic aneurysms. Clinical assessment is unre- 
liable. 11 Screening by ultrasound is inexpensive, quick, 
non-invasive and has been demonstrated reliably to 
detect and measure asymptomatic AAAs. 12 There are 
several studies evaluating the clinical consequences of 
routine ultrasound screening. 4'13-~5 
The following criteria are used to evaluate proposed 
screening programmes) 6"~7 
(1) The condition sought should pose an important 
health problem. 
(2) The natural history of the disease should be well 
understood. 
(3) There should be a recognisable early stage. 
(4) Treatment of the disease at an early stage should 
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be of more benefit than treatment at a later 
stage. 
(5) There should be a suitable test. 
(6) The test should be acceptable to the 
population. 
(7) There should be adequate facilities for the 
diagnosis and treatment of abnormalities 
detected. 
(8) For disease of insidious onset, screening should 
be repeated at intervals determined by the 
natural history of the disease. 
(9) The chance of physical or psychological harm to 
those screened should be less than the chance of 
benefit. 
(10) The cost of a screening programme should be 
balanced against he benefit it provides. 
Ultrasonic screening for AAA meets most of these 
criteria. However, there are still uncertainties about 2, 
9 and 10; the epidemiology ofAAA, the net benefits of 
screening and the ratio of cost to benefit. Nevertheless, 
the authors of a recent study concluded that AAA 
screening for aneurysms of _> 5cm should not be 
introduced 18whereas the conclusion for AAA above 
6cm was that national screening should be 
established. 19 
We report simulation studies examining screening 
elderly males for aneurysms of5 or 6cm. The analysis 
leads to estimates of the cost per additional quality 
adjusted life year (QALY) for the screened popula- 
tion. 2° We explore the sensitivity of our conclusions to 
differing assumptions about key risk measures and 
assumptions about the uptake of the service by 
eligible men. 
Methods 
Computer modelling provides a means of abstracting 
the essential features of a complicated system, process 
or service. This assists an exploration of the conse- 
quences of altering various of the assumptions under- 
lying the screening programme. 
The epidemiological assumptions 
A variety of sources were found to be helpful for 
making assumptions about the prevalence of aneu- 
rysms of differing sizes, the growth rate of aneurysms 
and the risk of rupture of aneurysms of differing 
sizes. ~2"2~-25 It was necessary to make some judge- 
ments when quoted estimates differed and a simple 
calculation was required to derive annual risks of 
rupture. Details of these considerations are available 
from the authors. Many of the initial epidemiological 
assumptions are shown in the top section of Table 1. 
The assumptions about he growth of aneurysms were 
mean annual growth rates of 0.26 cm, 0.46 cm and 0.66 
cm for aneurysms of sizes 3.0-3.9 cm, 4.04.9 cm and 
5.0-5.9 cm respectively. 
Cost data 
The cost data came from two sources. First an analysis 
of consecutive s ries of emergency (8) and elective (23) 
operation patients at Withington Hospital, Manches- 
ter, U.K. during 1992/3. The estimated costs for 
elective and emergency admissions (taken to surgery) 
were £2371 and £3914 respectively. For a pilot screen- 
ing programme offered to 600 men per year the static 
cost was estimated at £2150 and the incremental cost 
per scan at £2.50. The second set of data came from 
O'Kelly and Heather 21 and concern a programme 
screening 2500 men annually. These costs are circa 
1986 and we have not inflated them to current 
values. 
The model 
The model was implemented on a computer spread- 
sheet portraying AAA screening at a point when the 
service had reached equilibrium i.e. after the initial 
build up period when the annual intake of new clients 
became constant. 
The model was in two parts. The first looked at the 
consequences of screening in terms of operations 
performed (elective and emergency) and lives saved 
in the screened population. The second estimated the 
cost per life saved and the cost per QALY. 
The model followed a group of men over time. In 
the first year a number of asymptomatic men aged 
68-72 years were screened by ultrasound which was 
assumed to be precise in discriminating aneurysm 
size. For simplicity we assumed that all men with 
aneurysms _> 6cm accepted elective surgery. Those 
with AAA > 3 cm and < 6 cm were followed annually 
by repeat ultrasound examination until the end of the 
study or until the AAA grew to _> 6 cm. We also 
assumed that no aneurysms were detected as inci- 
dental findings to other clinical procedures. Men free 
of aneurysm were not routinely screened again. Figure 
1 provides an overview of the screening procedure. 
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Table 1. Screening for abdominal  aortic aneurysms in elderly men - -  Baseline Calculations 
Size Prevalence 
Key assumptions: 
Annual risk Annual 
of rupture growth 
Mortality: 
Overall 0.078 
3.0-3.9 0.053 0.000 
4.0-4.9 0.014 0.006 
5.0-5.9 0.005 0.035 
->6.0 cm 0.006 0.100 
Elective 0.05 Refusals 
Emergency 1.00 
0.26] 
0.46~ Low risk; screen annualy. 
0.66J 
High risk; offer elective surgery 
0.25 
Note: all calculations use full decimal places. 
However, results are presented rounded. 
2500 men invited for screening 
Year 1 
Category No. Deaths 
On the assumption that there is screening: 
Year 2 Year 3 Year 4 
No. Deaths No. Deaths No. Deaths 
Year 5 
No. Deaths 
No risk 2305.0 0 
3.00-3.24 33.1 0.0 
3.25-3.49 33.1 0.0 
3.50-3.74 33.1 0.0 
3.75-3.99 33.1 0.0 
4.00-4.49 17.5 0.1 
4.50-4.99 17.5 0.1 
5.00-5.39 5.0 0.2 
5.40-5.99 7.5 0.3 
a6,0 cm 15.0 0.9 
End of year 5: Survivors 2488 
Deaths = 12 
Operations 53 
2 
55 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 33.1 0.0 33.1 0.0 0.0 0.0 
33.1 0.2 33.1 0.2 33.1 0.2 33.1 0.2 
17.4 0.1 32.9 0.2 32.9 0.2 32.9 0.2 
17.4 0.6 17.3 0.6 32,7 1.1 32.7 1.1 
4.8 0.2 16.8 0.6 16.7 0.6 31.6 1.1 
10.6 0,7 7.0 0.4 17.8 1.1 20.1 1.3 
elective on high risk group (i.e.a6 cm aneurysms) 
emergency on low risk group (assuming 20% ruptures reach surgery) 
Total 
Year 1 
Category No. Deaths 
On the assumption that there is no screening: 
Year 2 Year 3 Year 4 
No. Deaths No. Deaths No. 
Year 5 
Deaths No. Deaths 
No risk 2305.0 0 
3.00-3.24 33.1 0.0 
3.25-3.49 33.1 0.0 
3.50-3.74 33.1 0.0 
3.75-3.99 33.1 0.0 
4.00-4.49 17.5 0.1 
4.50-4.99 17.5 0.1 
5.00-5.39 5.0 0.2 
5.40-5.99 7.5 0.3 
~6.0 cm 15.0 1.5 
End of year 5: Survivors 2477 
Deaths = 23 
Operations 5
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 
33.1 0.0 33.1 0.0 33.1 0.0 0.0 0.0 
33.1 0.2 33.1 0.2 33.1 0.2 33.1 0.2 
17.4 0.1 32.9 0.2 32.9 0.2 32.9 0.2 
17.4 0.6 17.3 0.6 32.7 1.1 32.7 1.1 
4.8 0.2 16.8 0.6 16.7 0.6 31.6 1.1 
20.7 2.1 23.3 2.3 37.2 3.7 49.6 5.0 
emergency (assuming 20% ruptures reach surgery) 
A few AAAs  wi l l  rupture  each year:  most  among 
men w i th  large aneurysms who dec l ined  screening,  
but  some among men w i th  smal l  aneurysms.  Since 
on ly  a smal l  p ropor t ion  of these  wi l l  reach  hosp i ta l  
a l ive  and  as operat ive  mor ta l i ty  is h igh  we,  for 
s impl ic i ty ,  assumed that  al l  these  pat ients  d ied.  
E lect ive  surgery  was  assumed to effect permanent  
"cure"  i.e. remova l  of  al l  fu ture  r i sk  of a ruptured  
aneurysm.  Each year  some of the  in i t ia l ly  smal l  
aneurysms wi l l  g row to > 6cm and be  t reated  by  
e lect ive  surgery.  
The mode l  fo l lowed a cohor t  of sc reened men for  5 
years.  Operat ions  (e lect ive and  emergency  separate ly )  
and  deaths  were  to ta l led  over  that  per iod .  The 
outcome wi th  sc reen ing  was  then  compared  w i th  that  
in same popu la t ion  over  5 years  had  there  been  no 
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2500 men aged 68-72 years 
1875 respond 625 non-responders 
1729 no risk ,~ reassure 576 no risk 
185 low risk ,~ re-screen in 1 year 45 low risk 
(8-5.9 era) (3-5.9 em) 
11 high risk ~ elective surgery 4 high risk 
(z6 cm) (z6 cm) 
Fig. 1. First year of screening for aneurysms of z 6 cm and assuming 
75% response. 
screening. The calculations in this instance were 
simpler, as all that had to be taken into account was 
the risk of spontaneous rupture in aneurysms of 
differing sizes and consequent emergency operations. 
For simplicit~ men were assumed not to be at risk of 
death over the 5 year period apart from that associated 
with aneurysms or their treatment. However, back- 
ground mortality was indirectly introduced through 
the calculation of the QALYs (see below). 
Table 1 shows how the model was implemented. 
The upper section displays the main assumptions; 
most can be varied. These were the baseline assump- 
tions (for screening aneurysms of a6.0 cm) from 
which the consequences of deviations were explored 
during sensitivity analysis. The middle section shows 
the results of screening. The bottom section shows the 
aneurysm related deaths and operations which would 
have occurred had the population not been offered 
screening. 
The final part of the model used the data from the 
above calculations and applied costs. Table 2 shows 
how costs from O'Kelly and Heather zl were applied to 
the results flowing from the baseline assumptions. The 
costs were of two kinds: the fixed annual cost of 
administration for the screening service and a variable 
(or incremental) cost dependent on the number of 
scans performed. The apportioned fixed cost makes 
allowance for the additional costs engendered by 
clients re-screened in later years. The total (5 year) cost 
of scanning applies the O'Kelly and Heather cost per 
scan to the total number of scans performed in the 
model over years. 21 These costs were added to the 
costs of elective and emergency treatments to give a 
total cost of screening. Similarly the costs (emergency 
treatment) engendered when there is no screening 
were calculated. From these the cost per net life saved 
Table 2. Cost calculations 
Assumptions:- 
1. Screening for aneurysms of size 6cm and more 
2. Costs based on O'Kelly and Heather at prices circa 1986 
3. Two thousand and five hundred men invited for screening per 
year 
4. Screening programme at equilibrium 
5. Screen entire responding eligible population once 
6. Annual screen of low risk aneurysms for further 4 years 
7. Elective surgery for all men with high risk aneurysms 
Cost of emergency treatment £3200.0 
Cost of elective treatment £1824.0 
Static screening cost per year £11950.0 
Cost per scan £2.8 
Total (5 year) marginal cost of screening £6663.3 
Apportioned fixed cost £14362.7 
Total cost of elective procedures £96502.5 
Total cost of emergency procedures £5177.8 
Total cost £122706.2 
Cost if no screening programme (emergency operations) £14509.9 
Lives saved (calculated from model) 10.2 
Cost per life saved by screening £10636.3 
Calculation of cost per QALY:- 
Years extra expectation oflife at age 70 10.0 
Years of life saved 101.7 
Cost per QALY (assuming lives saved at full quality 
and no discounting of benefit) £1206.3 
by introducing a screening programme was 
calculated. 
Calculating QALYs 
Men in England and Wales aged 70 years have an 
expectation of life of about 12 years. We assumed that 
the presence of an electively repairable aneurysm 
6cm gives a life expectancy of two years. Ruptured 
aneurysms are almost always fatal (zero quality life 
thereafter). Elective repair should restore normal life 
expectancy and age-related quality of life; this was 
predicated on the assumption that abdominal aortic 
aneurysms were independent of co-morbidity. So, it 
was assumed that successful elective repair of an 
aneurysm confers 10 years of life at full quality. This 
benefit was discounted at 5% per annum to an 
equivalent benefit of 7.7 quality adjusted life years; we 
assumed that the benefit accrued at the end of each 
year. 2° Discounting of benefit is done to give greater 
weight to more immediate gains (quality life years) 
than to anticipated gains further in the future. As 
discounting is a widespread practice we have used it 
to enable direct comparison of our figures with costs 
per QALY quoted for other screening programmes. 
The benefit (i.e. 10 or, if discounted 7.7, quality 
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years) was multiplied by the net number of lives saved 
to give quality years of life saved. This divided into 
the screening cost gave the absolute cost per QALY 
gained (Table 2). The net additional cost per QALY 
gained was calculated in a similar way but after 
subtracting from the screening costs the costs which 
would have been engendered treating spontaneously 
ruptured aneurysms had there been no screening 
programme. 
Findings on Baseline Assumptions 
Tables 1 and 2 show the model's findings when 2500 
men were offered screening and surgery for AAA > 
6cm aneurysms. 
With screening this population would experience 55 
operations, two of which would be emergency proce- 
dures for rupture. There would be twelve deaths; with 
two or three of these due to elective surgery. In the 
absence of screening, there would be 23 deaths due to 
ruptured aneurysms with only five surviving to 
achieve mergency operation. Screening leads to a net 
saving of 10 lives at a cost per life saved of £10636 
(circa 1986 costs). The absolute cost (circa 1986) per 
QALY was £1206 with undiscounted benefit and £1567 
with benefit discounted at 5% per annum. The net 
additional costs per QALY were £1064 and £1381, 
undiscounted and discounted respectively. 
The Manchester calculations were based on the 
assumption that a practicable pilot study would entail 
screening 600 men each year. On this scale, the service 
saved between two and three lives per year at a cost 
per life saved of £12850 (1992/3 prices). The absolute 
cost per QALY was £1459 with undiscounted benefit 
and £1928 with discounted benefit; the corresponding 
net additional costs per QALY were £1285 and £1698 
respectively. 
Bearing in mind price inflation since 1986, the two 
estimates of cost per QALY based on O'Kelly & 
Heather ~'1 and the Manchester model were remarkably 
consistent. 
Sensitivity Analyses 
To assess the importance of deviations from the 
baseline assumptions, one variable only was changed 
at any one time with all the others kept at their 
baseline values. Absolute cost per QALY with benefit 
not discounted, using O'Kelly and Heather ~1 cost 
assumptions (circa 1986) and screening for a popu la -  
Table 3. Summary of the sensitivity analyses: the effect on the 
cost/QALY* is shown for deviations of some of the assumptions 
from their baseline values (see text) 
% Refusing 
screening 0 10 20 25t 30 50 80 
£Cost/QALY 1180 1180 1199 1206 1214 1266 1516 
% Elective 
operative mortality 0 2 4 5% 6 8 10 
£ Cost/QALY 957 1043 1147 1206 1272 1429 1630 
Prevalence 
per 1000 of 
AAA >6 cm 1 3 5 6% 7 10 20 
£Cost/QALY 1660 1421 1265 1206 1156 1043 851 
Annual % 
rupture risk 
AAA ~6 cm 2 5 9 10t 11 15 20 
£ Cost/QALY 65067 2932 1358 1206 1088 797 615 
Annual % 
rupture risk 
AAA 5-6 cm 0.5 1 2 3.5% 5 10 20 
£Cost/QALY 1180 1185 1193 1206 1220 1266 1365 
*Absolute cost/QALY (not discounted) using O'Kelly and Heather 21 
costs (circa 1986); similar findings arise using Manchester costs (circa 
1992/3) and bear in mind that hese centre around an estimated cost 
per QALY of about £1500. Also, note that the precision of the 
cost/QALY figures is specious; the detail has been presented only to 
aid comparison among the values within the table. 
tBaseline value. 
tion of 2500 men, is the outcome index. The sensitivity 
analyses are summarised in Table 3. 
The findings from the model were insensitive to the 
level of uptake of the screening service. Similarly, 
variations of elective operative mortality within the 
range likely to pertain in practice (3-7%) have little 
effect. Halving the estimate of the prevalence of large 
aneurysms (~ 6cm) had little effect. Increasing the 
population prevalence of large aneurysms reduced the 
cost per QALY. Halving the annual risk of rupture of 
large aneurysms more than doubled the cost per 
QALY and thereafter reductions in risk increased the 
cost dramatically; conversely, increasing the risk of 
rupture causes rapid reductions in the cost per QALY. 
The model was not very sensitive to changes in the 
assumption about the annual risk of rupture of 
aneurysms within the range of 5-6cm. Altering the 
risk from smaller aneurysms had negligible effect. 
Increasing the expectation of life in the presence of a 
large aneurysm also increases cost per QALY. For 
expectations of life of 3, 4 and 5 years the costs per 
QALY become £1340, £1508 and £1723 respectively. 
Doubling the static cost of the screening programme 
increases the cost per QALY by 12% to £1347. 
Doubling the cost per scan increases the cost per 
QALY by 5% to £1272. Doubling the cost of emergency 
treatment increases the cost per QALY by 4% to £1257 
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Table 4. Summary of baseline calculations for aneurysms of a6 cm and also the consequences of offering elective surgery for aneurysms 
of ~5 cm 
No screening Screening Net outcome 
Elective Emerg. Elective Emerg. Net lives Cost per Cost per 
Scheme Deaths  operations operations Deaths  operations operations saved saved life QALY 
L H 23 0 5 12 53 2 10 £10600 £1200 
L M 5 0 1 3 13 0 2 or 3 £12850 £1500 
8H 23 0 5 21 226 0 2 £200000 £20700 
L H elective surgery for aneurysms z6.0 cm, O'Kelly and Heather ~1 costs (circa 1986); L M as above but based on Manchester options and costs 
(circa 1992/3); S H elective surgery for aneurysms z5.0 cm O'Kelly and Heather 21costs (circa 1986). 
Note: (a) figures have been rounded. 
(b) display of absolute cost per QALY not discounted. 
and doubling the cost of elective treatment raises the 
cost per QALY by 79% to £2155. 
The manner in which the model was specified and 
its supporting epidemiological data do not make it 
feasible to explore the consequences of offering elec- 
tive surgery across a continuous range of aneurysm 
sizes. Nevertheless it was feasible to explore the 
consequences of offering elective surgery for aneu- 
rysms of a 5 cm. In this instance the cost per QALY 
was markedly larger and ranged between £21000 and 
£30000 on various assumptions about survival with an 
untreated aneurysm. As elective surgery became ver 
more frequent in the model the costs soared and the 
net saving of lives also diminished because there were 
more deaths from elective surgery. The findings for 
aneurysms a 5cm and __. 6cm are brought ogether in 
Table 4. 
Discussion 
Our model followed up populations of men for 5 years 
after screening offered at around 70 years of age. For 
simplicity we ignored background mortality. That is, 
we did not allow for the fact that some men with 
aneurysms would die from unrelated causes. From 
1981, england and Wales mortality data it can be 
deduced that 74% of men aged 70 years survive to 75 
years. The greater part of the cost and potential benefit 
in our model arose in the year of first screening and 
the year thereafter (for those invited to re-screening). 
Thus, the effects of background mortality would be 
very small and would have applied equally to the 
screened and control groups. Moreover, the expecta- 
tion of life at age seventy which we used in computing 
the cost per QALY was derived from current life-table 
analysis which incorporates mortality from all 
causes. 
The epidemiological data were problematic. There 
was a large literature but much of this information 
was unusable because denominator populations were 
ill-defined or otherwise inappropriate. However, we 
independently arrived at prevalence stimates and 
risk rates broadly comparable with those employed by 
others. 1s'19 The sensitivity analysis gave some con- 
fidence that our findings were not greatly influenced 
by substantial deviations from our assumptions. The 
data from which we derived the annual rates of 
progression of aneurysms are sparse and not wholly 
satisfactory. We suggest that, in the context of a 
screening programme with high uptake, a faster rate 
of progression would reduce the cost per QALY 
because there would be fewer spontaneous ruptures 
arising from men being observed until elective sur- 
gery can be arranged. Slower rates of progression 
would increase the cost per QALY but this may not be 
of much significance as the greatest yield comes at first 
screening. 
Our baseline assumption that the expectations of 
life at age 70 years in the presence of a large aneurysm 
(--- 6 cm) is 2 years may seem pessimistic and not 
wholly in accord with our other epidemiological 
assumptions. The baseline annual risk was 10% and 
the background annual mortality risk is of the order of 
6-9% (England and Wales, 1981) in the age group 
70-79 years. These risks combine to about 17%. If this 
were a constant annual risk then 50% of men would 
die within 3-4 years. However, we believe that the 
estimated annual risk was conservative because no 
allowance has been made for the growth of large 
aneurysms and for differential risks among aneu- 
rysms at varying sizes above 6 cm. The sensitivity 
analysis did show that increasing the expectation of 
life for men with large aneurysms also increases the 
cost per QALY. 
The cost per QALY is inversely proportional to the 
years of benefit o be gained from elective surgery. If it 
were to be argued that in some populations the 
prevalence of aneurysms is strongly associated with 
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the prevalence of cardiovascular nd cerebrovascular 
disease then the 10 year benefit expected from elective 
surgery in this analysis may be too optimistic. Our 
figures can easily be scaled accordingly; for example 
reducing benefit to 5 years (undiscounted) would 
double our baseline stimate of the cost per QALY. 
Deviations from our simplifying assumption that 
ultrasound screening is 100% sensitive and 100% 
specific will inflate the cost per QALY. Nevertheless, 
from evidence cited earlier we believe the technique to 
be reliable when used by properly trained personnel 
and in the context of quality control monitoring. 
We propose that a reasonable present day estimate 
of the absolute cost per QALY gained from screening 
for AAAs of -_ 6 cm is in the region of £1500 to £1900. 
MakJng allowance for the inevitable expense of 
treating ruptured aneurysms when there is no screen- 
ing programme puts the additional cost per QALY for 
a screening programme in the range £1300 to £1700. 
These figures are greater than those of Law et al. 19 
Nevertheless both sets of figures compare favourably 
with kidney transplantation, breast cancer screening 
and heart transplantation at respectively £3000, 
£3-5000 and £5000 per QALY (1983-84 prices). 26 For 
aneurysms of > 5cm our findings are in agreement 
with those of Mason et al. 18 and we concur with them 
in concluding that screening for aneurysms of > 5cm 
is not worthwhile. 
There are practical and ethical issues to be con- 
sidered before routine screening for a 6cm AAA can 
be implemented. The net gain in QALYs was at the 
expense of life years for those who die as a con- 
sequence of elective surgery. How individuals hould 
be counselled about their choice between long term 
gains versus a risk of immediate death is uncertain 
and depends upon health professionals. 
Perhaps the most important practical issue is that of 
the size of aneurysm deemed suitable for elective 
surgery. If a programme were introduced offering 
surgery for ~ 6cm AAA, there would always be the 
temptation to operate on them at 5.5 cms. This 
temptation would be especially strong at centres 
consistently achieving better than 5% operative 
mortality. 
Our results demonstrate that AAA screening is 
tenable and the problems urmountable. The develop- 
ment and evaluation of AAA screening should be 
encouraged at centres of excellence in vascular 
surgery. 
Availability of additional material 
In order to keep this paper to a reasonable ngth it has 
been necessary to omit some details (seen by the 
referees) of the epidemiological assumptions, cost 
estimation and the computer model specification. 
These may be obtained by request o the authors. 
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